Developer docs
API playgroundTry for free, no card

Search company profiles

NewMed Energy

Full company profile

uuid000ao2d

Namestring
NewMed Energy
Legal namestring
NewMed Energy – Limited Partnership
Company typeenum
Public
Founded yearint
1993
Short descriptiontext

NewMed Energy is Israel's leading energy partnership focused on offshore natural gas exploration, development, and production in the Eastern Mediterranean. It holds 45.34% of Leviathan, the Mediterranean's largest gas field, exporting to Egypt, Jordan, and the region.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersHerzliya, Israel
HQ citystring
Herzliya
HQ countrystring
Israel
HQ regionstring
Middle East
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
natural gas exploration, offshore gas production, hydrocarbon exploration, energy partnership, gas field development
Industry4 codes
1Production Operations & Artificial Lift (Surface Facilities, Compression, Flow Assurance)
CodeEUAAAAAKPrimaryYes
2Oil & Gas Facilities Asset Management (Refining/Terminals/LNG)
CodeEUAEAMAGPrimaryNo
3Natural Resources — Energy & Mineral Resources
CodeFSAAAKAJPrimaryNo
4Development Management & Owner’s Engineering (Design Basis, Yield, Technical Due Diligence)
CodeEUAMAAAGPrimaryNo
NAICS code2 codes
  • Fuel Dealers45721
  • Pipeline Transportation of Refined Petroleum Products486910
SIC code3 codes
  • Crude Petroleum & Natural Gas1311
  • Oil & Gas Field Exploration Services1382
  • Oil & Gas Field Services, Nec1389
Product category
Natural Gas Exploration and Production
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Natural Gas Sales
TypeTransaction Fee
Description

NewMed Energy generates revenue primarily from the sale of natural gas produced from the Leviathan field. Gas is sold under long-term contracts to domestic Israeli customers (Israel Electric Corporation, industrial users) and regional export customers (Egypt, Jordan). Contracts typically feature take-or-pay provisions ensuring minimum revenue. The landmark $35 billion agreement with Egypt for 130 BCM over 15 years represents the largest export transaction in Israel's history.

newmedenergy.com
2Condensate Sales
TypeTransaction Fee
Description

Alongside natural gas production, NewMed Energy sells condensate extracted from the gas fields. Condensate is sold to refineries and petrochemical companies. The company has established agreements with companies like Ashdod Refinery for condensate offtake.

newmedenergy.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Operations, Infrastructure, Supply Chain, Personnel, Technology or R&D
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

NewMed Energy is Israel's leading energy partnership engaged in the exploration, development, production and sale of natural gas and condensate from offshore reservoirs in the Eastern Mediterranean. The company holds a 45.34% working interest in the Leviathan field, the largest gas reservoir in the Mediterranean, and a 30% interest in the Aphrodite field in Cyprus EEZ. It sells gas domestically to the Israel Electric Corporation and industrial users, and exports under long-term contracts to Egypt (130 BCM over 15 years, ~$35 billion), Jordan via NEPCO, and other regional customers.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 6 values shown
  • 70% reduction in pollutant emissions from power generation in Israel from 2013-2020 due to natural gas transition
+5 more records
Product overview1 text field

NewMed Energy is an Israeli energy partnership (formerly Delek Drilling) focused on the exploration, development, production and sale of natural gas and condensate in the Eastern Mediterranean. The company operates a portfolio of producing and development-stage assets anchored by the Leviathan field (45.34% stake, Mediterranean region), the Aphrodite field in Cyprus (30% stake), and various exploration licenses in Israel, Morocco, and Bulgaria. A $2.36 billion expansion of Leviathan Phase B is underway to increase production capacity to 21 bcm annually by 2029. The company has pivoted toward diversification through alternative energies including hydrogen production and carbon capture and storage, while continuing regional gas exports to Egypt, Jordan, and UAE under long-term agreements totaling approximately $35 billion. The portfolio spans production assets, development projects, and exploration opportunities.

Product and service4 records
1Leviathan Natural Gas Field
CategoryUpstream Natural Gas Production
2Leviathan Phase B Expansion
CategoryUpstream Natural Gas Production
3Aphrodite Natural Gas Field
CategoryUpstream Natural Gas Production
4Alternative Energies (Hydrogen, CCS, Renewables)
CategoryAlternative Energy / Decarbonization
Scale indicator13 records

Each record includes

Type, Value, Description, Source

Partnership11 partners
Strategic tierExplorationTypeStrategic or Co-development PartnerAnnounced on2026-04-03
Description

NewMed Energy Balkan partnered with OMV Offshore Bulgaria and Bulgarian Energy Holding EA to explore the Krum-1 well in the Black Sea. The well was drilled but found no significant gas volumes, with the partnership continuing to analyze results and costs.

Strategic tierStrategicTypeStrategic or Co-development PartnerAnnounced on2023-10-30
Description

SOCAR partnered with NewMed Energy (33.33%) and BP (33.33%) in a Joint Bidding Agreement for the 4th Offshore Bidding Round (OBR4), awarded six exploration licenses in Cluster I within Israel's EEZ. SOCAR acts as the designated operator. Licenses are adjacent to the producing Leviathan field.

Strategic tierStrategicTypeStrategic or Co-development PartnerAnnounced on2023-10-30
Description

BP partnered with NewMed Energy (33.33%) and SOCAR (33.33%) in a Joint Bidding Agreement for the 4th Offshore Bidding Round (OBR4), awarded six exploration licenses in Cluster I within Israel's EEZ. The partnership leverages BP's global upstream expertise and NewMed Energy's regional knowledge.

Strategic tierStrategicTypeStrategic or Co-development PartnerAnnounced on2023-03-13
Description

NewMed Energy signed detailed agreements with Enlight Renewable Energy and the CEO to enter the renewable energy sector. NewMed is exploring and investing in major renewable energy projects in attractive regions globally, leveraging its knowledge, capabilities, and regional market relationships.

Strategic tierExplorationTypeStrategic or Co-development PartnerAnnounced on2022-12-06
Description

NewMed Energy signed agreements with Adarco Energy and Morocco's National Office of Hydrocarbons and Mines (ONHYM) to explore the Boujdour Atlantique license off Morocco's Atlantic coast. NewMed holds 37.5%, Adarco 37.5%, and ONHYM 25%. First exploration well scheduled approximately 2.5 years after license grant.

Strategic tierStrategicTypeStrategic or Co-development PartnerAnnounced on2019-12-01
Description

NewMed Energy sold its holdings in the Tamar reservoir to Mubadala Petroleum of Abu Dhabi in December 2021 for approximately $1 billion, marking the largest transaction between Israeli and UAE companies following the Abraham Accords normalization agreements.

7Government of Cyprus
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2019-11-01
Description

The Government of Cyprus granted the Aphrodite partners a 25-year production license (with option to extend 10 years) and approved the outline for field development. The Cypriot government continues to support negotiations between Aphrodite partners and Egypt for gas export arrangements.

newmedenergy.com
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2019-02-01
Description

NewMed Energy, together with Chevron and Egyptian East Gas Company, acquired control of the EMG pipeline connecting Egyptian and Israeli transmission systems. This ensures implementation of the export contracts to Egypt and provides infrastructure for regional gas trade.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2017-01-01
Description

Chevron operates the Leviathan gas field and holds approximately 39.66% working interest. NewMed Energy (45.34%) and Ratio Energies (15%) are the other partners. Together they approved the $2.36 billion FID for Leviathan expansion in January 2026. Chevron also partners on the Aphrodite field in Cyprus (35% stake). The partnership represents the operational backbone of NewMed Energy's core business.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2011-09-01
Description

Shell holds 35% working interest in the Aphrodite gas field in Cyprus EEZ alongside NewMed Energy (30%) and Chevron (35%). The partnership is advancing development plans including FEED studies with planned floating production facility and subsea pipeline to Egypt. FID expected in 2027, with first gas anticipated in 2031.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2010-12-01
Description

Ratio Energies holds 15% working interest in the Leviathan gas field as the third partner alongside NewMed Energy (45.34%) and Chevron (39.66%). Ratio is an Israeli energy company focused on natural gas exploration and production in the Eastern Mediterranean.

Recent move9 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeRegional player
Description

Azerbaijani state oil company and designated operator of Cluster I exploration licenses in Israel alongside NewMed and BP (33.33% each). Comparable as a regional state-aligned upstream operator expanding into the Eastern Mediterranean.

TypeBroad incumbent
Description

Global IOC holding 35% of the Aphrodite field in Cyprus alongside NewMed and Chevron. Comparable as a partner in NewMed's development pipeline and a major global upstream player with Eastern Mediterranean interests.

TypeOthers
Description

Controlling shareholder of NewMed Energy, an Israeli conglomerate with energy, fuel retail, and financial services operations. Relevant as the parent group and an indicator of broader strategic alignment.

TypeBroad incumbent
Description

Italian IOC operating the Zohr gas field offshore Egypt, the largest gas field in the Mediterranean before Leviathan. Directly relevant as a Mediterranean gas producer and a key regional counterparty for Egyptian LNG exports.

TypeBroad incumbent
Description

Global IOC partnered with NewMed Energy and SOCAR in Cluster I exploration licenses in Israel's EEZ (33.33% each). Relevant as a strategic exploration partner and global upstream major.

TypeOthers
Description

Egyptian state gas company and largest contracted buyer under the $35B / 130 BCM export agreement with NewMed and partners. Relevant as the key offtake counterparty and a major regional gas player.

TypeDirect peer
Description

London-listed E&P company operating the Karish-Tanin gas fields offshore Israel, acquired from NewMed/Delek Drilling in 2016. Directly comparable as a regional Mediterranean gas producer serving the same Israeli and regional customers.

TypeBroad incumbent
Description

Global IOC operating the Leviathan field (39.66% interest) and partnering in Aphrodite (35%). Comparable as a partner and major upstream operator with overlapping Mediterranean exposure and broader global upstream portfolio.

TypeRegional player
Description

Abu Dhabi-based national petroleum company that acquired NewMed's Tamar reservoir stake in 2021 for ~$1B. Comparable as a regional Gulf-based upstream investor active in Israeli gas assets.

TypeDirect peer
Description

Israeli natural gas exploration and production company holding 15% of the Leviathan field alongside NewMed Energy and Chevron. Comparable as a direct co-partner and Israeli-listed Eastern Mediterranean gas player.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks7 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers7 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries3 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

NewMed Energy

Natural Gas Exploration and Productionnewmedenergy.com

NewMed Energy is Israel's leading energy partnership focused on offshore natural gas exploration, development, and production in the Eastern Mediterranean. It holds 45.34% of Leviathan, the Mediterranean's largest gas field, exporting to Egypt, Jordan, and the region.

NewMed Energy firmographics

Firmographics
Name
NewMed Energy
Legal name
NewMed Energy – Limited Partnership
Website
https://newmedenergy.com
Company type
Public
Founded year
1993
Operating status
Operating
Headcount range
51–100 employees
Short description
NewMed Energy is Israel's leading energy partnership focused on offshore natural gas exploration, development, and production in the Eastern Mediterranean. It holds 45.34% of Leviathan, the Mediterranean's largest gas field, exporting to Egypt, Jordan, and the region.
Ownership category
akta.pro rank

NewMed Energy industry classification

Industry
Product category
Natural Gas Exploration and Production
NAICS
Fuel Dealers (45721), Pipeline Transportation of Refined Petroleum Products (486910)
SIC
Crude Petroleum & Natural Gas (1311), Oil & Gas Field Exploration Services (1382), Oil & Gas Field Services, Nec (1389)
akta.pro primary industry
Production Operations & Artificial Lift (Surface Facilities, Compression, Flow Assurance) (EUAAAAAK)
akta.pro secondary industries
Oil & Gas Facilities Asset Management (Refining/Terminals/LNG) (EUAEAMAG), Natural Resources — Energy & Mineral Resources (FSAAAKAJ), Development Management & Owner’s Engineering (Design Basis, Yield, Technical Due Diligence) (EUAMAAAG)

Keywords

  • Natural gas exploration
  • Offshore gas production
  • Hydrocarbon exploration
  • Energy partnership
  • Gas field development

Where NewMed Energy is headquartered

Location

Headquarters

HQ city
Herzliya
HQ country
Israel
HQ region
Middle East

Offices1 record

Markets served

NewMed Energy business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Operations, Infrastructure, Supply Chain, Personnel, Technology or R&D

Revenue model

  1. Natural Gas Sales: NewMed Energy generates revenue primarily from the sale of natural gas produced from the Leviathan field. Gas is sold under long-term contracts to domestic Israeli customers (Israel Electric Corporation, industrial users) and regional export customers (Egypt, Jordan). Contracts typically feature take-or-pay provisions ensuring minimum revenue. The landmark $35 billion agreement with Egypt for 130 BCM over 15 years represents the largest export transaction in Israel's history.
  2. Condensate Sales: Alongside natural gas production, NewMed Energy sells condensate extracted from the gas fields. Condensate is sold to refineries and petrochemical companies. The company has established agreements with companies like Ashdod Refinery for condensate offtake.

Go-to-market motion1 record

Distribution channels5 records

Marketing channels5 records

NewMed Energy product offering

Product offering

Core offering

NewMed Energy is Israel's leading energy partnership engaged in the exploration, development, production and sale of natural gas and condensate from offshore reservoirs in the Eastern Mediterranean. The company holds a 45.34% working interest in the Leviathan field, the largest gas reservoir in the Mediterranean, and a 30% interest in the Aphrodite field in Cyprus EEZ. It sells gas domestically to the Israel Electric Corporation and industrial users, and exports under long-term contracts to Egypt (130 BCM over 15 years, ~$35 billion), Jordan via NEPCO, and other regional customers.

Product overview

NewMed Energy is an Israeli energy partnership (formerly Delek Drilling) focused on the exploration, development, production and sale of natural gas and condensate in the Eastern Mediterranean. The company operates a portfolio of producing and development-stage assets anchored by the Leviathan field (45.34% stake, Mediterranean region), the Aphrodite field in Cyprus (30% stake), and various exploration licenses in Israel, Morocco, and Bulgaria. A $2.36 billion expansion of Leviathan Phase B is underway to increase production capacity to 21 bcm annually by 2029. The company has pivoted toward diversification through alternative energies including hydrogen production and carbon capture and storage, while continuing regional gas exports to Egypt, Jordan, and UAE under long-term agreements totaling approximately $35 billion. The portfolio spans production assets, development projects, and exploration opportunities.

Differentiator

Problem solved

Functional benefit

Products and services

  • Leviathan Natural Gas Field
  • Leviathan Phase B Expansion
  • Aphrodite Natural Gas Field
  • Alternative Energies (Hydrogen, CCS, Renewables)

Quantifiable outcome

  • 70% reduction in pollutant emissions from power generation in Israel from 2013-2020 due to natural gas transition
  • +5 more outcomes

Companies that use NewMed Energy

Customer profile

Named customers7 records

Segments2 records

Ideal customer profiles2 records

NewMed Energy technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

NewMed Energy partnerships and signals

Strategic signal

Partnerships

Eleven partnerships are on record, tiered exploration, strategic and core.

  • OMV Offshore BulgariaexplorationStrategic or Co-development Partner · 3 April 2026NewMed Energy Balkan partnered with OMV Offshore Bulgaria and Bulgarian Energy Holding EA to explore the Krum-1 well in the Black Sea. The well was drilled but found no significant gas volumes, with the partnership continuing to analyze results and costs.
  • SOCAR (Azerbaijan State Oil Company)strategicStrategic or Co-development Partner · 30 October 2023SOCAR partnered with NewMed Energy (33.33%) and BP (33.33%) in a Joint Bidding Agreement for the 4th Offshore Bidding Round (OBR4), awarded six exploration licenses in Cluster I within Israel's EEZ. SOCAR acts as the designated operator. Licenses are adjacent to the producing Leviathan field.
  • BPstrategicStrategic or Co-development Partner · 30 October 2023BP partnered with NewMed Energy (33.33%) and SOCAR (33.33%) in a Joint Bidding Agreement for the 4th Offshore Bidding Round (OBR4), awarded six exploration licenses in Cluster I within Israel's EEZ. The partnership leverages BP's global upstream expertise and NewMed Energy's regional knowledge.
  • Enlight Renewable Energy LtdstrategicStrategic or Co-development Partner · 13 March 2023NewMed Energy signed detailed agreements with Enlight Renewable Energy and the CEO to enter the renewable energy sector. NewMed is exploring and investing in major renewable energy projects in attractive regions globally, leveraging its knowledge, capabilities, and regional market relationships.
  • Adarco EnergyexplorationStrategic or Co-development Partner · 6 December 2022NewMed Energy signed agreements with Adarco Energy and Morocco's National Office of Hydrocarbons and Mines (ONHYM) to explore the Boujdour Atlantique license off Morocco's Atlantic coast. NewMed holds 37.5%, Adarco 37.5%, and ONHYM 25%. First exploration well scheduled approximately 2.5 years after license grant.
  • Mubadala Petroleum (Abu Dhabi)strategicStrategic or Co-development Partner · 1 December 2019NewMed Energy sold its holdings in the Tamar reservoir to Mubadala Petroleum of Abu Dhabi in December 2021 for approximately $1 billion, marking the largest transaction between Israeli and UAE companies following the Abraham Accords normalization agreements.
  • Government of CypruscoreStrategic or Co-development Partner · 1 November 2019The Government of Cyprus granted the Aphrodite partners a 25-year production license (with option to extend 10 years) and approved the outline for field development. The Cypriot government continues to support negotiations between Aphrodite partners and Egypt for gas export arrangements.
  • Egyptian East Gas CompanycoreStrategic or Co-development Partner · 1 February 2019NewMed Energy, together with Chevron and Egyptian East Gas Company, acquired control of the EMG pipeline connecting Egyptian and Israeli transmission systems. This ensures implementation of the export contracts to Egypt and provides infrastructure for regional gas trade.
  • Chevron (Chevron Mediterranean Limited)coreStrategic or Co-development Partner · 1 January 2017Chevron operates the Leviathan gas field and holds approximately 39.66% working interest. NewMed Energy (45.34%) and Ratio Energies (15%) are the other partners. Together they approved the $2.36 billion FID for Leviathan expansion in January 2026. Chevron also partners on the Aphrodite field in Cyprus (35% stake). The partnership represents the operational backbone of NewMed Energy's core business.
  • ShellcoreStrategic or Co-development Partner · 1 September 2011Shell holds 35% working interest in the Aphrodite gas field in Cyprus EEZ alongside NewMed Energy (30%) and Chevron (35%). The partnership is advancing development plans including FEED studies with planned floating production facility and subsea pipeline to Egypt. FID expected in 2027, with first gas anticipated in 2031.
  • Ratio EnergiescoreStrategic or Co-development Partner · 1 December 2010Ratio Energies holds 15% working interest in the Leviathan gas field as the third partner alongside NewMed Energy (45.34%) and Chevron (39.66%). Ratio is an Israeli energy company focused on natural gas exploration and production in the Eastern Mediterranean.

Scale indicators13 records

Recent moves9 records

Expansion highlights6 records

NewMed Energy competitors and assessment

Company assessment

Regional players

  • SOCAR (State Oil Company of Azerbaijan Republic): Azerbaijani state oil company and designated operator of Cluster I exploration licenses in Israel alongside NewMed and BP (33.33% each). Comparable as a regional state-aligned upstream operator expanding into the Eastern Mediterranean.
  • Mubadala Petroleum: Abu Dhabi-based national petroleum company that acquired NewMed's Tamar reservoir stake in 2021 for ~$1B. Comparable as a regional Gulf-based upstream investor active in Israeli gas assets.

Broad incumbents

  • Shell plc: Global IOC holding 35% of the Aphrodite field in Cyprus alongside NewMed and Chevron. Comparable as a partner in NewMed's development pipeline and a major global upstream player with Eastern Mediterranean interests.
  • Eni S.p.A. Italian IOC operating the Zohr gas field offshore Egypt, the largest gas field in the Mediterranean before Leviathan. Directly relevant as a Mediterranean gas producer and a key regional counterparty for Egyptian LNG exports.
  • BP plc: Global IOC partnered with NewMed Energy and SOCAR in Cluster I exploration licenses in Israel's EEZ (33.33% each). Relevant as a strategic exploration partner and global upstream major.
  • Chevron Corporation: Global IOC operating the Leviathan field (39.66% interest) and partnering in Aphrodite (35%). Comparable as a partner and major upstream operator with overlapping Mediterranean exposure and broader global upstream portfolio.

Others

  • Delek Group: Controlling shareholder of NewMed Energy, an Israeli conglomerate with energy, fuel retail, and financial services operations. Relevant as the parent group and an indicator of broader strategic alignment.
  • Egyptian Natural Gas Holding Company (EGAS): Egyptian state gas company and largest contracted buyer under the $35B / 130 BCM export agreement with NewMed and partners. Relevant as the key offtake counterparty and a major regional gas player.

Direct peers

  • Energean: London-listed E&P company operating the Karish-Tanin gas fields offshore Israel, acquired from NewMed/Delek Drilling in 2016. Directly comparable as a regional Mediterranean gas producer serving the same Israeli and regional customers.
  • Ratio Energies: Israeli natural gas exploration and production company holding 15% of the Leviathan field alongside NewMed Energy and Chevron. Comparable as a direct co-partner and Israeli-listed Eastern Mediterranean gas player.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

NewMed Energy social profiles

Digital presence

NewMed Energy financial estimates

Financial estimate

Revenue estimate

Valuation estimate

NewMed Energy leadership team

Management profile

Number of profiles

Profiles1 record

NewMed Energy subsidiaries and ownership

Company hierarchy

Subsidiaries3 records

NewMed Energy funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

NewMed Energy M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about NewMed Energy

What does NewMed Energy do?

NewMed Energy is Israel's leading energy partnership engaged in the exploration, development, production and sale of natural gas and condensate from offshore reservoirs in the Eastern Mediterranean. The company holds a 45.34% working interest in the Leviathan field, the largest gas reservoir in the Mediterranean, and a 30% interest in the Aphrodite field in Cyprus EEZ. It sells gas domestically to the Israel Electric Corporation and industrial users, and exports under long-term contracts to Egypt (130 BCM over 15 years, ~$35 billion), Jordan via NEPCO, and other regional customers.

Is NewMed Energy a public or private company?

NewMed Energy is a public company. It is classified as public and is currently operating.

When was NewMed Energy founded?

NewMed Energy was founded in 1993. It employs 51 to 100 people.

Where is NewMed Energy based?

NewMed Energy is headquartered in Herzliya, Israel, in the Middle East region.

How does NewMed Energy make money?

Two revenue lines are on record. Natural Gas Sales are the primary driver. The others are condensate Sales.

Who are NewMed Energy's main competitors?

Regional players on record are SOCAR (State Oil Company of Azerbaijan Republic) and Mubadala Petroleum. Broad incumbents are Shell plc, Eni S.p.A., BP plc and Chevron Corporation. Others are Delek Group and Egyptian Natural Gas Holding Company (EGAS). Direct peers are Energean and Ratio Energies.

Does NewMed Energy have an API?

No public API is recorded for NewMed Energy.

What industry is NewMed Energy in?

NewMed Energy's product category is Natural Gas Exploration and Production. Its primary akta.pro industry code is EUAAAAAK, Production Operations & Artificial Lift (Surface Facilities, Compression, Flow Assurance), with a secondary code of EUAEAMAG, Oil & Gas Facilities Asset Management (Refining/Terminals/LNG). Its NAICS code is 45721 and its SIC code is 1311.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
GlobesNewMed insists $6.7b deal with Dalia Energy cancelledNewMed Energy LP cancelled a $6.7 billion gas supply agreement with Dalia Energy, citing unmet pre-conditions, though the Competition Authority had approved the deal. Dalia Energy insists the agreement remains in force and may pursue legal action.Simply Wall StRatio Energies (TASE:RATI) Cancels Dalia Deal As Investors Question Whether The Units Look PriceyRatio Energies and NewMed Energy cancelled a $6.7B natural gas supply deal with Dalia Energy for two Israeli power plants, citing unmet conditions. The partnership's units trade at a P/E of 13.3x, above the industry average of 11.9x, while a DCF fair value of ₪1.31 per unit is well below the current price.GlobesLeviathan partners cancel $6.7b deal with Dalia EnergyNewMed Energy and Ratio Energies cancelled a $6.7 billion gas supply deal with Dalia Energy for two 850-MW power plants. The cancellation cites failure to meet preconditions, including finance and competition authority approval. Dalia rejected the move, and the deal is expected to proceed on unspecified terms.Cyprus MailCyprus, Israel aim to seal Aphrodite-Ishai gas deal by end of OctoberCyprus and Israel will continue negotiations in the first half of October to reach an agreement over the cross-border gas reservoir between Cyprus' Aphrodite field and Israel's Ishai field. The talks are technical and involve officials, legal advisers, and operating companies. Cyprus expects Chevron, NewMed Energy, and BG Group to sign a final investment decision for Block 12 next year.YahooNewMed Energy Partners with GeoIntelX to Accelerate Natural Gas E&P Using the GIX AI PlatformNewMed Energy and GeoIntelX announced a collaboration to deploy GeoIntelX's GIX AI platform on two of NewMed's natural gas projects. The platform digitized and enriched NewMed's database, enabling AI-powered analysis of geological and commercial questions. NewMed sees gains in efficiency and insight during this first phase.PR NewswireNewMed Energy Partners with GeoIntelX to Accelerate Natural Gas E&P Using the GIX AI PlatformNewMed Energy and GeoIntelX announced a partnership to deploy GeoIntelX's GIX AI platform on two of NewMed's natural gas projects. The platform digitized and enriched NewMed's database, enabling faster geological analysis and decision-making. NewMed sees gains in efficiency and insight during this first phase.Simply Wall St3 Oil And Gas Stocks For Inflation Hedging In 2026Three large-cap integrated oil and gas stocks—NewMed Energy, DCC Energy, and OQ Gas Networks—are highlighted for inflation hedging in 2026. NewMed Energy generates about $848 million from exploration and production, while DCC Energy and OQ Gas Networks have market values of roughly £5.4b and OMR956.6 million respectively. The article notes heavy capital commitments and potential financing shifts could affect margins.AInvestNewMed's Q2 Profit Jumped 45% on Record Output-Can the Pipeline Gains Keep the Stock Rising?NewMed reported a significant rebound in its second quarter, achieving a net profit of $117.8 million on revenues of $293.2 million, driven by increased gas sales and higher production capacity. The company completed the third pipeline from the field to the platform, expanding annualized peak production capacity to 15.8 BCM, which is crucial for sustained cash flow and revenue growth. Forward-looking concerns remain regarding project timelines and infrastructure development, which will be critical for future performance.YahooNewMed Energy LP (DKDRF) (Q2 2026) Earnings Call Highlights: Record Production and Strategic ...NewMed Energy LP reported record Q2 2026 financial results, with revenue rising to $293 million and net profit increasing to $117 million, driven by higher gas production and prices. The company completed the Ashdod-Ashkelon pipeline looping to boost Egyptian market deliveries and highlighted significant asset value appreciation following Shell's sale of the Aphrodite field to MOL.Simply Wall StIs NewMed Energy Limited Partnership (TASE:NWMD) Below Fair Value As Strong Q2 Earnings Land?NewMed Energy, Limited Partnership reported Q2 2026 revenue of US$250.1 million and net income of US$117.8 million, with shares closing at ₪16.2. The company is currently trading below analyst fair value estimates of ₪17.9 despite strong long-term shareholder returns. However, significant capital commitments to the Leviathan phase two and Aphrodite projects present risks to future free cash flow.